[Edaily Starin Gim Ga Yeong Reporter] Hollywood actor Ansel Elgort has sparked controversy after appearing at an event in South Korea wearing traditional Japanese attire. Photo: Ansel Elgort’s social media account
Ansel Elgort attended the “CJ Night in Celebration of Frieze Seoul” event held at an art museum in Hannam-dong, Yongsan-gu, Seoul, on the afternoon of the 2nd. However, Ansel Elgort attended the event wearing a yukata, a traditional Japanese garment. The organizers had notified attendees that the dress code was “Cocktail Attire,” which refers to semi-formal attire. Yet Ansel Elgort’s choice of attire—which was unrelated to the event’s theme and deviated from the dress code—raised questions. Upon seeing Ansel Elgort’s outfit, Korean netizens left comments on his social media accounts such as, “Why did you wear a yukata to a Korean event?”, “I’m disappointed by this lack of manners,” “Did you do this on purpose?”, and “I don’t know what you were thinking when you wore that.” “CJ Night in Celebration of Freeze Seoul” is an event organized by CJ Group to invite figures from the domestic and international art worlds, as well as leaders from various fields of K-culture, to experience the K-lifestyle firsthand and engage in cultural exchange. Attendees at this event included the married couple Lee Byung-hun and Lee Min-jung, Lee Jung-jae, singer G-Dragon, and director Park Chan-wook. Meanwhile, Ansel Elgort rose to fame through his roles in films such as “Divergent,” “The Perks of Being a Wallflower,” “West Side Story,” and “Baby Driver.”
Lotte Auto Lease is entering the public corporate bond market backed by a principal and interest payment guarantee from its parent company, LOTTE rental. The company plans to raise a total of 30 billi…
SamsungElectroMechanics is projected to post its best-ever earnings this year, with operating profit approaching 2 trillion won. As demand for components used in artificial intelligence (AI) servers s…
AprilBio Co.,Ltd. CI. (Photo courtesy of AprilBio Co.,Ltd.)
AprilBio Co.,Ltd.(397030)has obtained early preclinical data for its dual-target RNA interference (RNAi) candidate. With a single adminis…